JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...

JMP Securities has reaffirmed its Market Outperform rating and a price target of $41.00 on Exelixis stock (NASDAQ:EXEL), aligning with the broader analyst consensus that sees upside potential.

JMP Securities analyst Matthew Condon initiated coverage of Trade Desk (TTD) with an Outperform rating and $150 price target The firm says the ...

On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.24 or -7.59% from the prior close of $3.16. The stock opened at $3.17 and ...

Benchmark believes that Roku can benefit meaningfully from establishing partnerships with other platforms and further ...

Investigators reportedly found that JMP Pizza Inc. allowed three children to work longer and later hours than laws permit.

JMP Securities initiated coverage of Roku (ROKU) with an Outperform rating and $95 price target The firm says the company is well positioned ...

Federal officials said five children were involved in the violations at a Farmington Hills location on 11 Mile.

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending antitrust litigation.The firm believes the Department of Justice case ...

Caesars Entertainment (NASDAQ:CZR – Free Report) had its target price lowered by JMP Securities from $57.00 to $53.00 in a research note published on Thursday morning,Benzinga reports.